Jacques F Meis, MD, PhD is an expert in Infectiology at Canisius-Wilhelmina Ziekenhuis (Netherlands). As of October 2026, ScienceLeadR ranks Jacques F Meis in the top 1% of experts worldwide for Mycoses. Jacques F Meis has authored 776 publications, the most recent in 2026. SLR score: 2,168 (community average: 125). How the SLR is computed.

LeadR Profile

Jacques F Meis, MD, PhD Canisius-Wilhelmina Ziekenhuis Netherlands
2 168 ScienceLeadR Reputation 2168
Network Map

Infectiology

Subspecialties: Public Health - Genetics - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1988 - 2026

Source: PubMed

University of Cologne

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 776

Citations

Citations: 51 067 1st author: 54 Last author: 179 Unique author: 3


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
In Vitro Activity and In Vivo Efficacy in a Murine Model of Rezafungin, Anidulafungin, Caspofungin, and Micafungin Against the Fifth Clade of Candida (Candidozyma) auris.
PMID 42646079 — micafungin, heart, brain, echinocandins, kidney, caspofungin, tissues, candida, anidulafungin
J Fungi (Basel)20260
Towards standardized antifungal susceptibility testing for Sporothrix brasiliensis.
PMID 42615133 — research design, laboratories, sporothrix, itraconazole, drug therapy, amphotericin b
J Antimicrob Chemother20260
Short tandem repeat genotyping of Pichia kudriavzevii isolates reveals long-standing clinical clade with high transmission potential.
PMID 42560405 — microsatellite repeats, disease outbreaks, pichia, genotype, tandem repeat sequences
Med Mycol20260
Reply to Chen et al., "Methodological considerations for the establishment of epidemiological cutoff values for Sporothrix species using CLSI broth microdilution".
PMID 42340338 — sporothrix, drug therapy, anti-bacterial agents, antiviral agents
Antimicrob Agents Chemother20260
Why intrinsic reduced susceptibility in rare fungal pathogens should be differentiated from intrinsic resistance: an ISHAM conceptual framework and narrative review.
PMID 42268236 — phenotype, classification, drug therapy, fungi, antiviral agents
Antimicrob Agents Chemother20260

LeadR Networks

Main global connection map